Lesion of the Pontine REM-Atonia Generator
trigger
The trigger is loss of function of the REM-on glutamatergic neurons of the sublaterodorsal nucleus (the rodent term; subcoeruleus in cat, and the homologous region in humans) or of their descending projection. Human evidence comes from the small number of cases in which structural brainstem lesions produce the syndrome, and consistently implicates the dorsal midbrain and pons. In the far commoner age-related form the lesion is degenerative rather than structural: alpha-synuclein pathology involving the pontine tegmentum, at a Braak stage that precedes nigral and cortical involvement. Conforming disorder nodes substitute the disorder-specific lesion - evolving synucleinopathy, a structural pontine lesion (stroke, demyelination, tumour), the orexin-deficiency-associated instability of narcolepsy type 1, or antidepressant exposure.
Downstream
-
Loss of Descending Glutamatergic Drive to Inhibitory Premotor Neurons
Loss of the REM-on population removes the excitatory drive its descending axons carry to medullary and spinal inhibitory premotor neurons.
Show evidence (2 references)
"The structure in man analogous to the subcoeruleus region in cat and sublaterodorsal nucleus in rat is proposed as the nucleus (and its associated efferent and afferent pathways) crucial to RBD pathophysiology."
Localises the trigger lesion to a specific brainstem nucleus and its pathways, which is what makes this a defined module rather than a general brainstem claim.
"Neuroimaging data from the few published human cases with RBD associated with structural lesions in the brainstem are presented, in which the dorsal midbrain and pons are implicated."
The human lesion evidence for this node, and the reason the animal circuitry is taken to translate: a discrete structural lesion at the homologous site reproduces the syndrome.
Loss of Descending Glutamatergic Drive to Inhibitory Premotor Neurons
amplifier
Atonia is not a passive withdrawal of excitation but an active inhibition: the descending glutamatergic limb excites glycinergic and GABAergic premotor neurons in the ventromedial medulla and spinal cord, which hyperpolarise skeletal motor neurons. Losing the drive therefore releases motor neurons from an inhibition that should be present, rather than merely failing to quiet them. This node is where the module's central anatomical claim sits: this descending pathway is separate from the ascending pathway that generates the EEG features of REM sleep, so it can be lost while REM sleep itself continues normally.
Downstream
-
Failure of REM Sleep Skeletal Muscle Atonia
Without descending excitation of the inhibitory premotor pool, skeletal motor neurons are not hyperpolarised during REM sleep and muscle tone persists.
Show evidence (2 references)
"In the REM-on area are two populations of glutamatergic neurons, the first of which projects to the basal forebrain and regulates EEG components of REM sleep and the second of which projects to the ventromedial medulla and spinal cord and regulates atonia during REM sleep."
The anatomical basis of the whole module: two separate output populations, one for EEG and one for atonia, which is what permits atonia to fail in isolation.
"Our findings demonstrating independent pathways mediating atonia and the EEG components of REM provide a basis for their occasional dissociation in pathological states, e.g. REM sleep behaviour disorder."
States the dissociation explicitly and names this disorder as its pathological instance, which is the claim the module's central node encodes.
Failure of REM Sleep Skeletal Muscle Atonia
central effector
The rate-limiting, disorder-agnostic node and the key conformance target, measurable as REM sleep without atonia: excess tonic or phasic electromyographic activity during scored REM sleep. It is a graded and quantifiable trait rather than a binary one, which matters clinically - quantified atonia loss is itself a predictor of progression in the degenerative form. Crucially, this node is separable from the clinical behaviours below it: REM sleep without atonia can be present without dream enactment, and a conforming entry should say which of the two it is evidencing, since only the electrophysiological finding is required for conformance.
Downstream
-
Motor Enactment of Dream Content During REM Sleep
With motor neurons no longer inhibited, the motor programmes generated during REM dreaming are executed rather than suppressed.
Show evidence (2 references)
"Rapid eye movement (REM) sleep behaviour disorder (RBD) is a parasomnia that is characterized by loss of muscle atonia during REM sleep (known as REM sleep without atonia, or RSWA) and abnormal behaviours occurring during REM sleep, often as dream enactments that can cause injury."
Defines the node and its polysomnographic name, and separates the electrophysiological finding from the behavioural one, which is the distinction the node description requires conformers to keep.
"A clinical history of dream enactment or complex motor behaviours together with the presence of muscle activity during REM sleep confirmed by video polysomnography are mandatory for a definite RBD diagnosis."
Establishes the measurement standard for this node - scored muscle activity during REM sleep on video polysomnography - which is what a conforming entry must be able to cite.
Motor Enactment of Dream Content During REM Sleep
effector
Released motor output takes the form of behaviour matched to dream content rather than random movement, which is the observation that ties the node to REM physiology rather than to a nonspecific motor release. Because REM dream content in this population is disproportionately confrontational, the behaviours are frequently violent - punching, kicking, leaping from bed - and the injury risk falls on both patient and bed partner. Movements are not preceded by the confusional arousal typical of an NREM parasomnia, and patients wake alert with dream recall, which is the bedside discriminator.
Downstream
-
Injury Risk and Prodromal Neurodegeneration
Enacted behaviour causes injury; and where the trigger lesion is degenerative, the same pathology progresses to involve nigral and cortical structures.
Show evidence (1 reference)
"REM sleep behaviour disorder (RBD) is a parasomnia characterized by the loss of normal skeletal muscle atonia during REM sleep with prominent motor activity accompanying dreaming."
Links the released motor activity specifically to dreaming, which is what makes this node an enactment of REM content rather than a generic motor release.
Injury Risk and Prodromal Neurodegeneration
consequence
Two consequences that must be kept apart. The first is immediate and mechanical: sleep-related injury to patient and bed partner, which is what treatment addresses. The second follows only from the degenerative route and is of a different kind - the pontine lesion is an early stage of a synucleinopathy whose later stages are Parkinson disease, dementia with Lewy bodies, or multiple system atrophy, so the parasomnia is a prodromal marker with a long lead time. Conversion is high but neither immediate nor universal, and the numbers matter: roughly 6% per year, with about three-quarters converting over twelve years. A conforming entry whose trigger is pharmacological or lesional should NOT inherit this second consequence.
Show evidence (3 references)
"The overall conversion rate from iRBD to an overt neurodegenerative syndrome was 6.3% per year, with 73.5% converting after 12-year follow-up."
Quantifies the prodromal consequence in a 1280-patient multicentre cohort, which is what allows the module to state the risk as a rate rather than as an association.
"Idiopathic REM sleep behaviour disorder (iRBD) is a powerful early sign of Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy."
Names the three destination diseases, which is what makes this node the link between the module and the synucleinopathy entries.
"colour vision abnormalities (HR = 1.69), constipation (HR = 1.67), REM atonia loss (HR = 1.54), and age (HR = 1.54)"
Cited for the finding that quantified atonia loss is itself among the significant predictors of phenoconversion, which is the evidence that the module's central node is graded rather than binary and carries prognostic information.